Moderna Gets $750 Million to Develop Flu Vaccine

Posted by ISPE Boston
On April 3, 2024

Moderna recently entered into a development and commercialization funding agreement with Blackstone Life Sciences to advance the company’s flu program. As part of the agreement, Blackstone will fund up to $750 million with a return based on cumulative commercial milestones and low-single digit royalties. Influenza leads to 3-5 million severe cases of flu and 290,000-650,000 […]

Stoke Therapeutics to Gross $125M from Sale of Shares

Posted by ISPE Boston
On April 3, 2024

Bedford biotech Stoke Therapeutics expects gross proceeds from its public offering of shares to reach $125 million. The offering is expected to close on or about April 2, 2024. Stoke is focused on addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary approach, the company is developing antisense […]

Transformative Impact: My Journey with ISPE from Aspiring Student to Emerging Professional

Posted by Attrayee Chakraborty
On March 25, 2024

Joining ISPE has changed my life. I still remember when I was checking out ISPE Boston in August 2022 as an aspiring student in regulatory affairs. Upon my arrival in the US, I joined ISPE in October 2022, marking the beginning of an extraordinary journey. My first event was at a EDEI event, where after […]

Orchard Therapeutics Sets $4.25M Price for Gene Therapy

Posted by ISPE Boston
On March 21, 2024

Orchard Therapeutics has received FDA approval for gene therapy Lenmeldy for the treatment of children with early-onset MLD, a rare and life-threatening inherited disease of the body’s metabolic system caused by a genetic mutation. The one-time, potentially life-saving treatment will carry a list price of $4.25 million, making the treatment the most-expensive ever approved according […]

AstraZeneca Adds RCs for Cancer with Fusion Buy

Posted by ISPE Boston
On March 21, 2024

AstraZeneca is buying Canadian clinical-stage biopharma Fusion Pharmaceuticals in a deal worth up to $2.4 billion. The acquisition of Fusion, a developer of radioconjugates (RCs) for cancer treatment, marks a major step forward in AstraZeneca’s goal to replace traditional cancer treatment regimens like chemotherapy and radiotherapy with more targeted treatments. RCs have emerged as a […]

Scholarship Application Opens on April 1st!

Posted by ISPE Boston
On March 14, 2024

Are you considering a career in biotechnology and pharmaceutical manufacturing? Are you currently an undergraduate or graduate student attending a recognized college or university in New England or the Albany/Schenectady area? Are you pursuing a STEM (Science, Technology, Engineering, or Mathematics) certification or degree? Do you need financial assistance for your education? If this sounds […]

Successful GAMP gathering at Trillium!

Posted by Haley Durbin
On March 12, 2024

The ISPE Boston GAMP Community of Practice (CoP) gathered at Trillium Brewery’s Canton location on Thursday, February 29th, not only to celebrate having one extra day in the year, but to bring together “GAMPers” from across the chapter for some delicious drinks and stimulating conversation! The newly formed committee hosted a casual get together to […]

A Sunny Day for the Annual Ski Trip!

Posted by Jim Grunwald
On March 8, 2024

We, the Social Programs Committee, send you a heartfelt thank you for participating in the 2024 version of our Annual Outing. Thank you to our volunteers, Kristin Dangelo and Nate Soucy for keeping things organized as bus captains, you both deserve a round of applause. So many folks to thank for their everlasting sponsorship of […]

Governor Healey Proposes Major Initiatives in Life Sciences

Posted by ISPE Boston
On March 7, 2024

Governor Healey has announced that she is reauthorizing the Life Sciences Initiative that has made Massachusetts a global leader in life sciences. The initiative proposes reauthorizing the Life Sciences Initiative at $1 billion for 10 years and will be included in the administration’s upcoming economic development bill, called the Mass Leads Act, which will require passage […]

Chapter Member Anniversaries: March 2024

Posted by ISPE Boston
On March 4, 2024

Please congratulate the following members celebrating milestone anniversaries in March 2024. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Anubhav Bhargava, Skanska USA Building Inc Andrew Collentro Charles Cooney, MIT Chemical Engineering Brian Duffy, Integrated Project Services Eric Felz Brian Hagopian, Clear Water Consulting, Inc. David Harney, […]

Page 10 of 116«‹8 91011 12 ›»